Beijing Succeeder Technology Inc (688338) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Beijing Succeeder Technology Inc (688338) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.97 Million ≈ $2.04 Million USD) by net assets (CN¥1.66 Billion ≈ $243.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Beijing Succeeder Technology Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Beijing Succeeder Technology Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Beijing Succeeder Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Succeeder Technology Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Succeeder Technology Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shaanxi Jinye Science Technology and Education Group Co Ltd
SHE:000812
0.148x
Galan Lithium Ltd
AU:GLN
-0.008x
TECSYS Inc.
TO:TCS
0.085x
Hanyang ENG Co. Ltd
KQ:045100
-0.045x
TAIDOC TECHNOLOGY CORP
TW:4736
0.024x
Source Capital Closed Fund
NYSE:SOR
-0.098x
Fiverr International Ltd
NYSE:FVRR
0.050x
Wuhan Sante Cableway Group Co Ltd
SHE:002159
0.074x

Annual Cash Flow Conversion Efficiency for Beijing Succeeder Technology Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Beijing Succeeder Technology Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Beijing Succeeder Technology Inc (688338) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.69 Billion
≈ $247.25 Million
CN¥79.40 Million
≈ $11.62 Million
0.047x -37.10%
2024-12-31 CN¥1.65 Billion
≈ $240.89 Million
CN¥122.98 Million
≈ $18.00 Million
0.075x +9.04%
2023-12-31 CN¥1.60 Billion
≈ $234.16 Million
CN¥109.64 Million
≈ $16.04 Million
0.069x +2.52%
2022-12-31 CN¥1.50 Billion
≈ $220.16 Million
CN¥100.56 Million
≈ $14.71 Million
0.067x -11.60%
2021-12-31 CN¥1.42 Billion
≈ $207.92 Million
CN¥107.42 Million
≈ $15.72 Million
0.076x +41.88%
2020-12-31 CN¥1.36 Billion
≈ $198.45 Million
CN¥72.27 Million
≈ $10.57 Million
0.053x -67.24%
2019-12-31 CN¥374.69 Million
≈ $54.83 Million
CN¥60.94 Million
≈ $8.92 Million
0.163x -45.28%
2018-12-31 CN¥195.65 Million
≈ $28.63 Million
CN¥58.15 Million
≈ $8.51 Million
0.297x +30.33%
2017-12-31 CN¥143.30 Million
≈ $20.97 Million
CN¥32.68 Million
≈ $4.78 Million
0.228x -32.88%
2016-12-31 CN¥103.89 Million
≈ $15.20 Million
CN¥35.30 Million
≈ $5.17 Million
0.340x --

About Beijing Succeeder Technology Inc

SHG:688338 China Medical Devices
Market Cap
$373.39 Million
CN¥2.55 Billion CNY
Market Cap Rank
#13875 Global
#4154 in China
Share Price
CN¥24.04
Change (1 day)
+0.46%
52-Week Range
CN¥23.93 - CN¥35.81
All Time High
CN¥126.75
About

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and… Read more